Credit Suisse’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Credit Suisse’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,000	Closed	-$234K	–	3950
2022 Q4	$234K	Hold	12,000	–	–	﹤0.01%	3132
2022 Q3	$251K	Hold	12,000	–	–	﹤0.01%	3155
2022 Q2	$384K	Hold	12,000	–	–	﹤0.01%	3007
2022 Q1	$489K	Sell	12,000 -12,000	-50%	-$503K	﹤0.01%	2993
2021 Q4	$1.07M	Hold	24,000	–	–	﹤0.01%	3262
2021 Q3	$1.2M	Hold	24,000	–	–	﹤0.01%	3194
2021 Q2	$1.3M	Buy	+24,000	New	+$1.2M	﹤0.01%	3183
2020 Q4	–	Sell	-14,139	Closed	-$627K	–	4488
2020 Q3	$627K	Hold	14,139	–	–	﹤0.01%	3255
2020 Q2	$544K	Hold	14,139	–	–	﹤0.01%	3275
2020 Q1	$582K	Buy	+14,139	New	+$677K	﹤0.01%	3018

Credit Suisse's ELAT Position: Q1 2023 in Review

Credit Suisse sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 12,000 shares — an estimated $234K sold.

Credit Suisse first reported a position in ELAT in Q1 2020 and held it in 10 quarters. The position peaked at $1.3M in Q2 2021. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

Credit Suisse reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 12,000 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $234K.
Credit Suisse first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 10 quarters.
Credit Suisse's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $1.3M in Q2 2021.
0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.